Research Pipeline

Programs at the Frontier of Community Health.

ZM BioSci funds and supports community-based screening research targeting conditions with high prevalence and low detection rates across Asian populations. Our programs are designed for long-term impact — built on peer-reviewed methodology and conducted in partnership with academic and clinical institutions.

Active Programs

Current Research Programs

Alzheimer's Screening

Active

Community Screening · Longitudinal

Early cognitive decline is often missed in routine clinical settings. This program deploys validated screening instruments across community cohorts to detect early markers of Alzheimer's disease, with the goal of enabling earlier intervention and contributing to longitudinal research on neurodegenerative risk in Asian populations.

Fatty Liver Screening

Active

Community Screening · Multi-Centre

Non-alcoholic fatty liver disease (NAFLD) is increasingly prevalent yet frequently undetected until advanced stages. This program screens community participants using non-invasive diagnostic tools, aiming to establish baseline prevalence data and identify at-risk subgroups for early clinical referral.

Helicobacter pylori Screening

Active

Community Screening · Multi-Centre

Helicobacter pylori infection is a leading cause of gastric ulcers and a recognised risk factor for gastric cancer. This program conducts large-scale community screening to identify infection prevalence, support early intervention, and generate population-level data across Hong Kong communities.

Collaborate With Us

Interested in Joining a Program?

We welcome enquiries from academic institutions, hospital networks, and clinical research organisations interested in multi-centre collaboration or data partnership.

ZM BioSci

A subsidiary of Zhiming Intellectual Property Co. Ltd.

Shanghai Zhiming Law Office

Shanghai Zhiming Trademark Agency Co., Ltd.

Room 1005–1006, No. 550 Baoding Mansion,
Xujiahui Rd., Shanghai 200025

Company

© 2023 ZM BioSci. A subsidiary of Zhiming Intellectual Property Company Limited, Shanghai Zhiming Law Office, and Shanghai Zhiming Trademark Agency Co., Ltd.

zmbiosci.com

.